Live Analyst Rating Changes 54325 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Courtney Breen
BERN

Courtney Breen

Bernstein
Wall Street Analyst
★★★★★
#28
on 13Foresight · ranked by our own returns
76%
Success Rate
+10.5%
Average Return
44 of 58 calls profitable · +9.9% vs benchmark
S&P 500 (SPY)
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 76% of Courtney Breen's ratings turned a profit when each position was held for 1 year — averaging +10.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

43 Buy 100 Hold 1 Sell
Courtney's Stock Coverage 9 ratings · 2026-11-08
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
LLY
Eli Lilly & Co
 Oct 26, 2026 BUY Strong Buy
-16.7% avg upside
50 analysts
$1450.00
2.33% Upside
 +6.7% ·
AMGN
Amgen
 Oct 25, 2026 HOLD Buy
-29.9% avg upside
57 analysts
$345.00
26.05% Downside
 +3.5% ·
BMY
Bristol-Myers Squibb
 Oct 25, 2026 HOLD Buy
-2.2% avg upside
42 analysts
$61.00
2.45% Downside
 +2.5% ·
GILD
Gilead Sciences
 Oct 25, 2026 BUY Strong Buy
-27.3% avg upside
66 analysts
$160.00
6.33% Downside
 +10.0% ·
PFE
Pfizer
 Oct 25, 2026 HOLD Buy
+9.1% avg upside
46 analysts
$29.00
5.03% Downside
 +0.1% ·
ABBV
AbbVie
 Oct 25, 2026 HOLD Strong Buy
-14.5% avg upside
47 analysts
$230.00
21.98% Downside
 +1.6% ·
MRNA
Moderna
 Oct 25, 2026 HOLD Hold
-48.5% avg upside
38 analysts
$45.00
79.72% Downside
 +27.8% ·
MRK
Merck & Company
 Oct 25, 2026 HOLD Strong Buy
-3.5% avg upside
44 analysts
$105.00
29.70% Downside
 +4.5% ·
GB:0QIU
Novo Nordisk
 May 12, 2026 SELL Hold
+52.9% avg upside
29 analysts
$175.00
34.13% Downside
 · ·
🔒 4 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Courtney Breen — Frequently Asked Questions
How accurate are Courtney Breen's stock ratings?
Based on the calls 13Foresight could measure, about 76% of Courtney's ratings were profitable over a one-year hold, with an average return of +10.5% per rating, or +10.0% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Courtney ranked on 13Foresight?
Courtney Breen is currently ranked #28 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Courtney cover?
Courtney most recently has ratings on LLY, AMGN, BMY, GILD, PFE, ABBV, MRNA, MRK, GB:0QIU. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.